US 12000829
Selection of patients for combination therapy
granted A61KA61K2039/54A61K2039/545
Quick answer
US patent 12000829 (Selection of patients for combination therapy) held by Syndax Pharmaceuticals, Inc. expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Syndax Pharmaceuticals, Inc.
- Grant date
- Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/54, A61K2039/545, A61K31/4406, A61K39/3955